Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 16/20 | 0.47 |
| ▸ | BCAT2 | O15382 | 14/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28736871 | 0.86 | BCAT1 (0.49) | BCAT1BCAT2ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL7690573 | 0.86 | BCAT1 (0.50) | BCAT1BCAT2ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL6231046 | 0.80 | BCAT1 (0.50) | BCAT1BCAT2ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL5846798 | 0.80 | BCAT1 (0.58) | BCAT1BCAT2 | |
| SCHEMBL7680274 | 0.78 | BCAT1 (0.52) | BCAT1BCAT2ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL24961338 | 0.78 | BCAT1 (0.54) | BCAT1BCAT2ALDH1A1CYP2C9CYP2C19 | |
| SCHEMBL24825954 | 0.78 | BCAT1 (0.61) | BCAT1BCAT2 | |
| SCHEMBL7038240 | 0.76 | BCAT1 (0.43) | BCAT1BCAT2MAPTALDH1A1CYP2C9 | |
| SCHEMBL8408460 | 0.75 | MAPT (0.41) | MAPTPKMMAPK1ALDH1A1CYP2C9 | |
| SCHEMBL7095909 | 0.75 | MAPT (0.41) | MAPTPKMMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030032807-A1 | Method for the production of 1-amino -3-aryl -uracils | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-13 | — | — | US | disclosed |
| US-4859229-A | HERBICIDES | HOFFMANN-LA ROCHE INC. (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0255047-A1 | 3-Aryl uraciles and their use as herbicides | CIBA-GEIGY AG (CH) | 1988-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032807-A1 | Method for the production of 1-amino -3-aryl -uracils | NQO2, QARS1, NUDT1 | BCAT1 378/4885BCAT2 451/4885MAPT 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.